UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients

Phase 1

Completed

Conditions: Acute Myelogenous Leukemia

Interventions: Drug: Decitabine

First Posted Date: 2014-04-10

Last Posted Date: 2022-07-05

Lead Sponsor: University of Rochester

Target Recruit Count: 27

Registration Number: NCT02109744

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)

Not Applicable

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cytosine Arabinoside

First Posted Date: 2014-04-02

Last Posted Date: 2018-06-27

Lead Sponsor: University of Rochester

Target Recruit Count: 11

Registration Number: NCT02101983

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Improving Communication About Patient Priorities in Multimorbidity

Not Applicable

Completed

Conditions: Chronic Disease

Interventions: Other: Care As Usual
Other: Customized Care

First Posted Date: 2014-04-01

Last Posted Date: 2018-04-26

Lead Sponsor: University of Rochester

Target Recruit Count: 60

Registration Number: NCT02100982

Locations: 🇺🇸
Highland Family Medicine, Rochester, New York, United States

Novel Topical Therapies for the Treatment of Genital Pain

Phase 2

Completed

Conditions: Female Genital Diseases

Interventions: Drug: placebo
Drug: Amitriptyline
Drug: Baclofen
Drug: Ketoprofen
Drug: Ketamine
Drug: Loperamide
Drug: Gabapentin

First Posted Date: 2014-03-28

Last Posted Date: 2016-07-15

Lead Sponsor: University of Rochester

Target Recruit Count: 9

Registration Number: NCT02099006

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Realizing Opportunities for Self Empowerment

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Enhanced Screening and Referral
Behavioral: Navigation

First Posted Date: 2014-03-14

Last Posted Date: 2019-01-07

Lead Sponsor: University of Rochester

Target Recruit Count: 223

Registration Number: NCT02087956

Locations: 🇺🇸
University of Rochester, Women Health Practice, Rochester, New York, United States

A Phase II Study of Doxycycline in Relapsed NHL

Phase 2

Terminated

Conditions: Marginal Zone B-Cell Lymphoma
Waldenstrom Macroglobulinemia
Small Lymphocytic Lymphoma
Adult Diffuse Large B-Cell Lymphoma
Mantle Cell Lymphoma Recurrent
Lymphoma, Follicular
Malignant Lymphoma - Lymphoplasmacytic
Chronic Lymphocytic Leukemia (CLL)
T-Cell Lymphoma

Interventions: Drug: Doxycycline

First Posted Date: 2014-03-13

Last Posted Date: 2016-12-22

Lead Sponsor: University of Rochester

Target Recruit Count: 7

Registration Number: NCT02086591

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Evaluating URMC's Massive Transfusion Protocol

Completed

Conditions: Blood Coagulation Disorders
Trauma
Acute Coagulopathy

Interventions: Other: Blood collection

First Posted Date: 2014-03-11

Last Posted Date: 2020-02-26

Lead Sponsor: University of Rochester

Target Recruit Count: 2

Registration Number: NCT02083549

Locations: 🇺🇸
Strong Hospital at University of Rochester Medical Center, Rochester, New York, United States

High-dose Vitamin D Supplementation for ADT-induced Side Effects

Not Applicable

Completed

Conditions: Prostatic Neoplasms
Bone Mineral Density Quantitative Trait Locus 3

Interventions: Dietary Supplement: vitamin D
Dietary Supplement: Placebo

First Posted Date: 2014-02-17

Last Posted Date: 2019-04-08

Lead Sponsor: University of Rochester

Target Recruit Count: 108

Registration Number: NCT02064946

Locations: 🇺🇸
Wilmot Cancer Center, University of Rochester, Rochester, New York, United States

Conditioned Pharmacotherapeutic Effects in Hypertension

Phase 4

Completed

Conditions: Hypertension

Interventions: Drug: carvedilol

First Posted Date: 2014-02-06

Last Posted Date: 2019-07-09

Lead Sponsor: University of Rochester

Target Recruit Count: 44

Registration Number: NCT02056626

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Effectiveness Trial of Youth Suicide Prevention Delivered by Teen Peer Leaders

Not Applicable

Completed

Conditions: Suicide Prevention

Interventions: Behavioral: Sources of Strength

First Posted Date: 2014-01-23

Last Posted Date: 2017-01-05

Lead Sponsor: University of Rochester

Target Recruit Count: 17603

Registration Number: NCT02043093

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy